Ampio Provides Corporate Update

ENGLEWOOD, Colo., Feb. 21, 2020 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment ("SPA") Phase III clinical tria... Biopharmaceuticals, Orthopaedic Ampio Pharmaceuticals, Ampion, osteoarthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news